- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05962372
Ensayo Clínico Dietético Adaptado Culturalmente en PR (PRECISION)
Ensayo Clínico Dietético Adaptado Culturalmente en PR: Evaluación en Puerto Rico de una Intervención Sostenible Culturalmente Informada para una Nutrición Óptima (PRECISION)
This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This intervention will culturally tailor a diet to the adult population in Puerto Rico based on staple foods as well as culturally appropriate strategies to reduce cardiometabolic risk factors. Based on preliminary results from studies on the island, investigators will conduct a 24-month, 2-arm intervention among 250-350 adults (125-175 per arm) ages 30-65 living in Puerto Rico with at least 1 of 5 cardiometabolic risk factors. The two arms are (1) intervention group with culturally-tailored portion-control Mediterranean Diet-like advice through monthly individual counseling for 12 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes, vegetable oils, and locally sourced assorted fruit and vegetables for 18 months; (2) control arm with portion-control standard non-tailored nutritional counseling in monthly individual sessions for 12 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18-24, we will monitor behavior maintenance (no food/voucher or counseling), with support from the nutritionist, and cues-to-action texts. Investigators will measure changes in cardiometabolic risk factors and metrics of eating behaviors and psychological factors. The two co-primary outcomes are changes in ASCVD score and cardiometabolic improvement score.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Natalia Torres, BS
- Número de teléfono: 787-523-1593
- Correo electrónico: natalia.torres@prcci.org
Ubicaciones de estudio
-
-
-
San Juan, Puerto Rico, 00926
- Reclutamiento
- Puerto Rico Consortium for Clinical Investigation
-
Contacto:
- Natalia Torres, BS
- Número de teléfono: 787-523-1593
- Correo electrónico: natalia.torres@prcci.org
-
Sub-Investigador:
- Amarilys F Sylva, PhD
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
-
Age 30-65y old at the time of enrollment
-
Non-institutionalized
-
Living in PR at the time of recruitment and for at least the previous year and not planning to move from the island within the next 3 years
-
Able to answer questions without assistance
-
Having a cellphone with the capacity to receive text messages and be willing to receive daily text messages from the study on the designated cellphone number
-
Having at least one of the following:
- elevated BMI
- elevated waist circumference
- self-reported physician-diagnosed hypertension or use of hypertension medication or measured high blood pressure at the baseline visit
- self-reported physician-diagnosed pre-diabetes or measured pre-diabetes at the baseline visit
- self-reported physician-diagnosed dyslipidemia or use of lipid-lowering agents or laboratory values confirming dyslipidemia
Exclusion Criteria:
- Under 30 or over 65 years of age (on the day of the interview).
- Currently not living in Puerto Rico or not lived on the island for at least 1 year or planning to move within 3 years
- Institutionalized
- Not able to answer questions without assistance
- Not having at least 1 of the five listed metabolic criteria
- Self-reported physician-diagnosed type 1 or type 2 diabetes or use of diabetes medication (including insulin) or diabetes-diagnosis values confirmed by laboratory
- Self-reported pregnancy
- Gastrointestinal or chronic condition that would impact eating behaviors or nutritional status
- Intolerance or allergies to legumes (i.e.: beans and nuts), vegetable oils (i.e.: corn, olive, canola), or fresh produce
- Living with another person participating in the study
- Participating in another research study that conflicts with PRECISION
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Triple
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention
Intervention group will receive culturally-tailored portion-control Mediterranean-like advice through monthly individual counseling for 6 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes (i.e., beans and peanuts), vegetable oils (i.e., olive oil + a blend of canola and soybean), and locally sourced assorted fruit and vegetables for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no food or counseling) with support from the nutritionist available. |
Puerto Rico-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc. |
|
Comparador activo: Control
Control group will receive portion-control standard non-tailored nutritional counseling in monthly individual sessions for 6 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no voucher or counseling), with support from the nutritionist available. |
Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips included in the My Plate For A Healthy Puerto Rico dietary recommendations. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
10-year risk score for a first atherosclerotic CVD event (ASCVD score)
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in first atherosclerotic CVD event (ASCVD) score; the score is calculated using the Pooled Cohort Equation which accounts for biological sex, age, race, total cholesterol, HDL-C, systolic blood pressure, treatment for high blood pressure, current diabetes diagnosis, and smoking status. Scores are expressed as percentage (0-100) with higher scores indicative of higher 10-year risk for ASCVD event. It is categorized as low-risk <5%; borderline risk 5% to 7.4%; intermediate risk 7.5% to 19.9%; and high risk ≥20%. |
6; 12; 18; 24 months
|
|
Cardiometabolic Improvement Score (CIS)
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in the score; calculated as the added number of risk factors changed over a predefined value; range of 0 to 10; from less to more improvement. |
6; 12; 18; 24 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Changes in diet quality score
Periodo de tiempo: 6; 12; 18; 24 months
|
Determine the change in score of short diet quality screener (range 18-54; from lowest to highest quality) |
6; 12; 18; 24 months
|
|
Changes in diet satisfaction: diet satisfaction scale
Periodo de tiempo: 6; 12; 18; 24 months
|
Determine the change in the score of the Diet Satisfaction Questionnaire (DSat-45) (range 45-225; from lowest to highest satisfaction) and its summed seven subscales (ranges 5-40) |
6; 12; 18; 24 months
|
|
Changes in intake of pre-specified food groups (fruit; vegetables; legumes; oils; meat; fat)
Periodo de tiempo: 6; 12; 18; 24 months
|
Determine the change in servings/week of food groups |
6; 12; 18; 24 months
|
|
Change in levels of waist circumference
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in the value of waist circumference (cm) |
6; 12; 18; 24 months
|
|
Change in levels of BMI
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in the value of body mass index (kg/m2) |
6; 12; 18; 24 months
|
|
Change in levels of blood pressure risk factors
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in the value of systolic and diastolic blood pressure (mmHg) |
6; 12; 18; 24 months
|
|
Change in levels of metabolic risk factors
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in the value of glucose, triglycerides, total cholesterol, LDL, HDL (mg/dL) |
6; 12; 18; 24 months
|
|
Change in food security status
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in food security status assessed by the USDA Food Security Module |
6; 12; 18; 24 months
|
|
Change in self-efficacy score
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in self-efficacy score assessed by the Nutritional Self-Efficacy Scale |
6; 12; 18; 24 months
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in social connectedness score
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in social connectedness score from the Social Connectedness Scale/Social Assurance Scale |
6; 12; 18; 24 months
|
|
Change in social support score
Periodo de tiempo: 6; 12; 18; 24 months
|
Estimate the change in social support score from the 12-item Social Support Scale |
6; 12; 18; 24 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Josiemer Mattei, PhD, MPH, Harvard Chan School of Public Health
- Director de estudio: Amarilys F Sylva, PhD, Puerto Rico Consortium for Clinical Investigations
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades del sistema endocrino
- Enfermedades Vasculares
- Enfermedades cardiovasculares
- Trastornos Nutricionales
- Enfermedades metabólicas
- Sobrenutrición
- Peso corporal
- Trastornos del metabolismo de la glucosa
- Diabetes mellitus
- Exceso de peso
- Hiperlipidemias
- Trastornos del metabolismo de los lípidos
- Condiciones Patológicas, Signos y Síntomas
- Enfermedades Nutricionales y Metabólicas
- Signos y síntomas
- Obesidad
- Hipertensión
- Diabetes Mellitus, Tipo 2
- Hiperglucemia
- Dislipidemias
- Hipertrigliceridemia
- Obesidad Abdominal
- Calidad, acceso y evaluación de la atención médica
- Técnicas de investigación
- Métodos epidemiológicos
- Recopilación de datos
- Mecanismos de evaluación de atención médica
- Calidad de la atención médica
- Salud pública
- Medio ambiente y salud pública
- Mediciones epidemiológicas
- Evaluación nutricional
Otros números de identificación del estudio
- IRB23-0951
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
IPD will be managed and distributed observing NIH and IRB policies on the dissemination and sharing of research results. Study information and requests for data will be available immediately upon the data being de-identified and properly revised for quality control by contacting study investigators.
Marco de tiempo para compartir IPD
10 years
Criterios de acceso compartido de IPD
The requested data will be shared with investigators via a secured, password-protected software website, upon request.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- CIF
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .